The HeartRunner Trial

Sponsor
Emergency Medical Services, Capital Region, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT03835403
Collaborator
TrygFonden, Denmark (Industry)
1,600
1
2
83.5
19.2

Study Details

Study Description

Brief Summary

The study will assess 30-day survival for cases where volunteer citizen responders ('heart runners') were activated through a smartphone app to retrieve an AED in case of suspected out-of-hospital cardiac arrest (OHCA) versus standard emergency medical services care. The study will randomize emergency medical dispatch center incoming calls which are suspected out-of-hospital cardiac arrest, such that half will be randomized to activation of heart runners and half to no activation of heart runners (standard care). The study will also assess physical or psychological risks involved for the activated heart runners.

Condition or Disease Intervention/Treatment Phase
  • Other: Activation of HeartRunners
N/A

Detailed Description

Chances of survival after out-of-hospital cardiac arrest decrease 10% per minute from collapse until defibrillation. Activating volunteer citizens through the emergency medical dispatch center can potentially increase rates of bystander defibrillation and survival. The HeartRunner trial will investigage the effect of activating registered volunteer citizens through a mobile app integrated with the emergency medical services on 30-day survival following out-of-hospital cardiac arrest. Both arms will receive standard care by the Emergency Medical Services. The intervention arm will additionally receive the activation of volunteer citizen responders. The randomization will take place independently in 3 different strata according to heart runner distance to OHCA (< 3 min, 3-9 min, > 9 min). The trial will also assess whether it is safe, both physically and psychologically, to activate volunteer citizen responders to respond to out-of-hospital cardiac arrests.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Public Access Defibrillation by Activated Citizen First-responders - The HeartRunner Trial
Actual Study Start Date :
May 15, 2019
Anticipated Primary Completion Date :
May 1, 2026
Anticipated Study Completion Date :
May 1, 2026

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care (control arm)

These cardiac arrests will receive standard EMS response.

Experimental: HeartRunner Activation

For these cardiac arrests, HeartRunners will be activated in addition to standard EMS response.

Other: Activation of HeartRunners
Activation of volunteer citizen first-responders to respond to nearby cardiac arrests

Outcome Measures

Primary Outcome Measures

  1. 30-day survival [30 days after date of out-of-hospital cardiac arrest]

    Patient alive 30 days after date of out-of-hospital cardiac arrest

Secondary Outcome Measures

  1. Rates of bystander defibrillation [During cardiac arrest]

    Percentage of patients who received defibrillation prior to EMS arrival

  2. Rates of bystander cardiopulmonary resuscitation [During cardiac arrest]

    Percentage of patients who received bystander cardiopulmonary resuscitation prior to EMS arrival

  3. Rates of return of spontaneuous circulation [Immediately after out-of-hospital cardiac arrest]

    sustained circulation indicating successful resuscitation

  4. Rates of survival after 1 year [1 year after date of out-of-hospital cardiac arrest]

    percentage of patients alive 1 year after out-of-hospital cardiac arrest

  5. Rates of neurological intact survival [At hospital discharge]

    percentage of patients with cerebral performance category score of 1-2

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All out-of-hospital cardiac arrests recognized by Emergency Medical Dispatcher and where the HeartRunner system is activated.

  • Non-traumatic etiology, this excludes intoxication, drowning or suicide.

  • Age > 7 years

Exclusion Criteria:
  • Caller is not in direct contact with the patient

  • If Emergency Medical Dispatcher deems AED is not indicated, e.g., in nursing homes where trained personal is present.

  • OHCAs not treated by the EMS due to ethical reasons or obvious signs of death

  • OHCAs with no heart runners within 1800 meters

  • Not true cardiac arrest (suspected, but not verified)

  • EMS-witnessed OHCAs

Emergency medical dispatchers are instructed not to activate heart runners in case any of the exclusion criteria above. However, since it can be challenging for emergency medical dispatchers to gather sufficient information about the patient within the first few minutes, heart runners will admittedly be activated even though they should not have been. Since randomization will occur for all cases in which a heart runner is activated, cases with any of the exclusion criteria will be secondarily excluded.

These cases will be accounted for but not included in analyses of outcome. Our pilot study showed approximately 60% of suspected cardiac arrests were true cardiac arrests. Therefore, we expect 40% of cases for which heart runners were dispatched not to be true cardiac arrests.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emergency Medical Services Copenhagen Copenhagen Ballerup Denmark

Sponsors and Collaborators

  • Emergency Medical Services, Capital Region, Denmark
  • TrygFonden, Denmark

Investigators

  • Principal Investigator: Fredrik Folke, MD, PhD, Copenhagen EMS

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Fredrik Folke, MD, PhD, Head of Research, Emergency Medical Services, Capital Region, Denmark
ClinicalTrials.gov Identifier:
NCT03835403
Other Study ID Numbers:
  • The HeartRunner Trial
First Posted:
Feb 8, 2019
Last Update Posted:
Dec 8, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 8, 2020